Clinical Trial Update: Locally Advanced NSCLC Hyperfractionated RT [Phase 2]

View source ↗

Summary

Phase 2 trial update on locally advanced non-small cell lung cancer using hyperfractionated radiotherapy; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Duke University | Conditions: Carcinoma, Non Small Cell Lung (NSCLC) | Phase 2 | Status: COMPLETED | Results posted: 2020-02-24